Medicinal Products

Sunitinib Pliva 12,5 mg tvrde kapsule

Name Sunitinib Pliva 12,5 mg tvrde kapsule
Marketing Authorisation Number HR-H-118479931
Active Substance sunitinib
Composition jedna kapsula sadrži 12,5 mg sunitiniba
Pharmaceutical Form kapsula, tvrda
Manufacturer Teva Operations Poland Sp. z o.o., Krakow, Poljska
Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka
Pliva Hrvatska d.o.o., Zagreb, Hrvatska
Balkanpharma - Dupnitsa AD, Dupnitsa, Bugarska
Actavis International Ltd., Luqa, Malta
Marketing Authorisation Holder Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska
Marketing Authorisation Date 17.02.2023
MA Period of Validity unlimited
Classification Number UP/I-530-09/22-02/53
Registration Number 381-12-01/171-23-04
Prescription Medicinal product subject to medical prescription
Type of prescription ograničeni recept
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code L01EX01
Marketing status stavljeno u promet
Shortage status nema nestašice
SmPC download
PL download
Public Assessment Report download

Packaging

Back